Another GSK and Nabi Deal Sends Positive Smoke Signals
By Taskin Ahmed
Pharma Deals Review: Vol 2009 Issue 11 (Table of Contents)
Published: 27 Nov-2009
DOI: 10.3833/pdr.v2009.i11.1278 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
GlaxoSmithKline (GSK) has reached an exclusive worldwide options and license agreement for a promising smoking cessation vaccine from Nabi Pharmaceuticals for more than US$500 M...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS